IDEXX beats ‘the Street’ on Q4 results, issues ’23 outlook

IDEXX Laboratories Inc. (NASDAQ) on Monday posted fourth-quarter earnings and revenues that beat estimates and issued a bullish initial outlook for 2023. 

The Westbroook-based provider of veterinary diagnostics, veterinary practice software and water testing reported earnings of $2.05 per share for the quarter that ended Dec. 31, beating the $1.92 per share consensus estimate of analysts polled by Zacks Investment Research. The figure compares to $1.89 per share for the third quarter of 2022. Read more

Related Posts

Husson creates institute for leadership and workforce development

Husson University in Bangor has launched an institute dedicated to strategic leadership and workforce development training and education.  Founded by the...

21 February 2023

Swiss optics supplier acquires Portland-based Gray Optics

The acquisition of Gray Optics in Portland by a Swiss photonics firm expands the latter’s presence in the U.S. while allowing...

17 February 2023

ElleVet Sciences, the Leading Pet CBD+CBDA Brand in the United States, Expands into Europe 

PORTLAND, Maine, Feb. 15, 2023 /PRNewswire/ — ElleVet Sciences announced today that it is expanding its global reach with its new European Headquarters...

15 February 2023